Latest news
Braveheart Bio prices IPO at $18 per share - BioXconomyBioXconomy · Thu, 06 Aug 2026 20:37:06 GMTSevere Nonischemic Dilated Cardiomyopathy Associated With Multi-Ingredient Herbal Supplement Use - JACC JournalsJACC Journals · Thu, 06 Aug 2026 16:11:13 GMTPediatric dilated cardiomyopathy and the progression to heart failure: mechanisms and interventions focusing on the “gene-inflammation-metabolism” axis - FrontiersFrontiers · Thu, 06 Aug 2026 07:00:00 GMTTenaya’s TN-201 Gene Therapy Shows Hypertrophy Reduction in HCM Patients - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTCardiomyopathy in Duchenne muscular dystrophy is focus of nearly $2M grant - Vanderbilt Health NewsVanderbilt Health News · Tue, 04 Aug 2026 13:36:16 GMTNavigating Life with Hypertrophic Cardiomyopathy - Williams-Grand Canyon NewsWilliams-Grand Canyon News · Mon, 03 Aug 2026 09:42:11 GMTMidventricular Hypertrophic Cardiomyopathy With Apical Aneurysm Presenting as Persistent ST-Segment Elevation Mimicking Acute Myocardial Infarction - JACC JournalsJACC Journals · Thu, 30 Jul 2026 01:52:22 GMT